The effect of fibrinogen concentrate administration on coagulation abnormalities in a rat sepsis model

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 1, 2004, Pages 39-43

  Kaspereit, Franz ^a   Doerr, Baerbel ^a   Dickneite, Gerhard ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Disseminated intravascular coagulation; Fibrinogen concentrate; Haemocomplettan P; Sepsis; Thrombelastography

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; FIBRINOGEN; HAEMOCOMPLETTAN P; THROMBIN ANTITHROMBIN COMPLEX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BODY WEIGHT; CIRCULATION; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; DRUG EFFECT; FEMALE; FIBRINOGEN BLOOD LEVEL; MEASUREMENT; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; REACTION TIME; SEPSIS; THROMBOELASTOGRAPHY;

ANIMALS; ANTITHROMBIN III; BLOOD COAGULATION; DISEASE MODELS, ANIMAL; FEMALE; FIBRINOGEN; HUMANS; LIPOPOLYSACCHARIDES; PEPTIDE HYDROLASES; PLASMA; RATS; SHOCK, SEPTIC; THROMBELASTOGRAPHY;

EID: 2042474132     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200401000-00007     Document Type: Article

References (26)

1. Levi M. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient J Crit Care 2001; 16:167-177.
2. Bick RL, Scates SM. Disseminated intravascular coagulation. Lab Med 1992; 23:161-165.
3. Bone RC. Sepsis and coagulation. An important link. Chest 1992; 101:594-596.
4. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101:816-823.
5. Hantagan RR, Francis CW, Marder VJ. Fibrinogen structure and physiology. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (editors): Hemostasis and thrombosis: basic principles and clinical practice, 3rd edition. Philadelphia: JB Lippincott Company; 1994, pp. 277-300.
6. Beck EA. Congenital abnormalities of fibrinogen. Clin Haematol 1979; 8:169-181.
7. Bick RL. Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response. Semin Thromb Hemost 1996; 22:69-88.
8. Levi M, ten Cate H. Current concepts. Disseminated intravascular coagulation. N Engl J Med 1999; 341:586-592.
9. Schopen G, Bonik K, Rosenkranz G. Fibrinogensubstitution mit Haemocomplettan HS. Hämostaseologie 1994; 14:140-148.
10. Garcia-Monco JC, Canton GF, Beldarrain MC. Bilateral vertebral artery dissection in a patient with afibrinogenemia. Stroke 1996; 27: 2325-2327.
11. Dickneite G, Czech J, Keuper H. Formation of fibrin monomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin. Circ Shock 1994; 42:183-189.
12. Nieuwenhuizen W. Soluble fibrin as a molecular marker for pre-thrombotic state: a mini review. Blood Coagul Fibrinolysis 1993; 4:93-96.
13. Kolde HJ. ChromoTimeSystem - a new generation of coagulation analyses. Behring Inst Mitt 1985; 78:176-187.
14. Wayne L, Chandler H. The thromboelastograph and the thromboelastograph technique. Semin Thromb Hemostas 1995; 21(suppl 4):1-6.
15. Keene ON. The log transformation is special. Stat Med 1995; 14: 811-819.
16. Marcus R, Peritz E, Gabriel K. On closed testing procedures with special reference to ordered analysis of variance. Biometrika 1976; 63: 655-660.
17. Dickneite G, Paques EP. Protection of DIC-induced mortality in Klebsiella pneumoniae-infected and LPS-treated rats by antithrombin III. In: Müller-Berghaus G (editor): DIC: pathogenesis, diagnosis and therapy of disseminated intravascular fibrin formation. Amsterdam: Elsevier Science Publishers BV; 1993, pp. 215-219.
18. Dati, F, Becker U, Hissung A, Keller F. New perspectives in diagnosis of hemostasis disorders. Ann Biol Clin (Paris) 1998; 46:201-210.
19. Bredbacka S, Blombäck M, Wiman B, Pelzer H. Laboratory methods for detecting disseminated intravascular coagulation (DIC): new aspects. Acta Anaesthesiol Scand 1993; 37:125-130.
20. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Thromb Haemost 2001; 86:1327-1330.
21. Dickneite G, Paques EP. Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis. Thromb Haemost 1993; 69:98-102.
22. Wilson RF, Farag A, Mammen EF, Fujii Y. Sepsis and antithrombin III, prekallikrein, and fibrinogen levels in surgical patients. Am Surg 1989; 55:450-456.
23. Vinazzer H. Antithrombin III in shock and disseminated intravascular coagulation. Clin Appl Thromb Hemost 1995; 1:62-65.
24. Dickneite G, Kroez M. Treatment of porcine sepsis with high-dose antithrombin III reduces tissue edema and effusion but does not increase risk for bleeding. Blood Coagul Fibrinolysis 2001; 12:459-467.
25. Blauhut B, Kramar H, Vinazzer H, Bergmann H. Substitution of antithrombin III in shock and DIC: a randomized study. Thromb Res 1985; 39: 81-89.
26. Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993; 104:882-888.